Arcus Biosciences
RCUS
P/S ratio for Arcus Biosciences (RCUS)
P/S ratio as of April 2024 (TTM): 12.1
According to Arcus Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.0882. At the end of 2023 the company had a P/S ratio of 12.2.
P/S ratio history for Arcus Biosciences from 2018 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 12.2 | -8.88% |
| 2022 | 13.4 | 80.61% |
| 2021 | 7.43 | -65.85% |
| 2020 | 21.7 | -29.59% |
| 2019 | 30.9 | -46.13% |
| 2018 | 57.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |